You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API CLOBAZAM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing CLOBAZAM

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Aquestive Therapeutics SYMPAZAN clobazam 10094-205 CITRIC ACID MONOHYDRATE
Aquestive Therapeutics SYMPAZAN clobazam 10094-205 GLYCERYL MONOOLEATE
Aquestive Therapeutics SYMPAZAN clobazam 10094-205 HYPROMELLOSES
Aquestive Therapeutics SYMPAZAN clobazam 10094-205 MALTITOL
Aquestive Therapeutics SYMPAZAN clobazam 10094-205 POLYETHYLENE OXIDE 200000
Aquestive Therapeutics SYMPAZAN clobazam 10094-205 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Aquestive Therapeutics SYMPAZAN clobazam 10094-205 SUCRALOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing CLOBAZAM

Company Ingredient NDC Excipient
West-Ward Pharmaceuticals Corp clobazam 0054-0526 LACTOSE MONOHYDRATE
West-Ward Pharmaceuticals Corp clobazam 0054-0526 MAGNESIUM STEARATE
West-Ward Pharmaceuticals Corp clobazam 0054-0526 SILICON DIOXIDE
West-Ward Pharmaceuticals Corp clobazam 0054-0526 STARCH, CORN
West-Ward Pharmaceuticals Corp clobazam 0054-0526 TALC
Hikma Pharmaceuticals USA Inc clobazam 0054-0561 ANHYDROUS CITRIC ACID
Hikma Pharmaceuticals USA Inc clobazam 0054-0561 MAGNESIUM ALUMINUM SILICATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for CLOBAZAM

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZOIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSPOVIDONE

Excipient focus: DIMETHICONE

Excipient focus: DIMETHICONE 410

Excipient focus: GLYCERYL MONOOLEATE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM ALUMINUM SILICATE

Excipient focus: MAGNESIUM ALUMINUM SILICATE TYPE IIA

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTITOL

Excipient focus: METHYLPARABEN

Excipient focus: MODIFIED CORN STARCH

Excipient focus: NITROGEN

Excipient focus: POLYETHYLENE OXIDE 200000

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: RASPBERRY

Excipient focus: SACCHARIN SODIUM

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBIC ACID

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: STRAWBERRY

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TRIACETIN

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links